Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 5, 2015, Pages

  Kew, Kayleigh M ^a   Dahri, Karen ^b,c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969974007     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011721     Document Type: Article

References (20)

1. Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD002738.pub2]
2. Adams NP, Bestall JC, Lasserson TJ, Jones P, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003135.pub4]
3. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma, October 2014. https://www.brit-thoracic.org.uk/guidelines-and-quality-standards/asthma-guideline/ (accessed 16 March 2015).
4. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2008, Issue 5. [DOI: 10.1002/14651858.CD005535.pub2]
5. Ducharme FM, Ni Choinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD005533.pub2]
6. Electronic Medicines Compendium. License extension 19th September 2014: Spiriva Respimat 2.5 micrograms solution for inhalation. https://www.medicines.org.uk/emc/history/20134 (accessed 16 March 2015).
7. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respiratory Medicine 2007;1001(6):1218-28.
8. Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org/ (accessed 16 March 2015).
9. International Union Against Tuberculosis and Lung Disease. The Global Asthma Report 2011. http://theunion.org/what-we-do/publications/technical/global-asthma-report (accessed 16 March 2015).
10. Brozek J, Oxman A, Schünemann H. GRADEpro. 3.2 for Windows. Hamilton, Ontario, Canada: McMaster University, 2008.
11. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
12. Kerstjens HAM, Engel M, Bateman ED. Tiotropium in asthma [correspondence]. New England Journal of Medicine 2012;367:2552-3.
13. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy. Archives of Internal Medicine 1999;159:941-55.
14. Lipworth BJ. Emerging role of long acting muscarinic antagonists for asthma. British Journal of Clinical Pharmacology 2014;77(1):55-62.
15. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]
16. Moulton BC, Fryer AD. Muscarinic receptor antagonists, from folklore to pharmacology: finding drugs that actually work in asthma and COPD. British Journal of Clinical Pharmacology 2011;163(1):44-52.
17. Royal College of Physicians. Why asthma still kills: the national review of asthma deaths. www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf (accessed 27 March 2015).
18. Pandya D, Puttanna A, Balagopal V. Systemic effects of inhaled corticosteroids: an overview. The Open Respiratory Medicine Journal 2014;8(Suppl 1):59-65.
19. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
20. McIvor RA. Respiratory disorders: chronic obstructive pulmonary disease. In: Gray J editor(s). Therapeutic Choices. 7th Edition. Ottawa: Canadian Pharmaceutical Association, 2014.